Inventor · disambiguated record
Venkat Reddy Mali
Also filed as: MALI VENKAT · MALI VENKAT REDDY
59 granted patents·5 pending applications·268 citations·filing 2011–2024
98Inventor score
Files withCHEMOCENTRYX INC52METABASIS THERAPEUTICS INC7ABBVIE INC2BIOTHERYX INC1GOMEZ-GALENO JORGE E1
Top patents by PatentIndex Score
64 records- 0198US9834545B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2016·Granted Dec 5, 2017·26 cites·33 claims
- 0297US11485708B2Compounds for treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Nov 1, 2022·9 cites·21 claims
- 0397US11266643B2Triaryl compounds for treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Mar 8, 2022·13 cites·32 claims
- 0497US9809581B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2016·Granted Nov 7, 2017·23 cites·29 claims
- 0596US11478460B2Diaryl substituted 6,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2020·Granted Oct 25, 2022·3 cites·34 claims
- 0696US10919852B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2018·Granted Feb 16, 2021·15 cites·25 claims
- 0796US10562896B26-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2018·Granted Feb 18, 2020·11 cites·38 claims
- 0895US11708326B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2020·Granted Jul 25, 2023·4 cites·25 claims
- 0995US9783540B2Substituted tetrahydropyrans as CCR2 modulatorsCHEMOCENTRYX INC·Filed 2016·Granted Oct 10, 2017·7 cites·45 claims
- 1094US11142521B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Oct 12, 2021·4 cites·6 claims
- 1194US10683294B25-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2018·Granted Jun 16, 2020·8 cites·31 claims
- 1294US10464934B2Substituted tetrahydropyrans as CCR2 modulatorsCHEMOCENTRYX INC·Filed 2017·Granted Nov 5, 2019·5 cites·13 claims
- 1394US10370363B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2017·Granted Aug 6, 2019·6 cites·13 claims
- 1494US10336736B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2017·Granted Jul 2, 2019·6 cites·24 claims
- 1594US10329314B2Soluble C5aR antagonistsCHEMOCENTRYX INC·Filed 2018·Granted Jun 25, 2019·12 cites·21 claims
- 1693US11479553B25-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2020·Granted Oct 25, 2022·3 cites·24 claims
- 1793US11384079B26-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2019·Granted Jul 12, 2022·5 cites·18 claims
- 1893US10828285B2Diaryl substituted 6,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2018·Granted Nov 10, 2020·5 cites·27 claims
- 1992US11485737B2Diaryl substituted 5,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2020·Granted Nov 1, 2022·2 cites·29 claims
- 2091US11446289B2Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitorsCHEMOCENTRYX INC·Filed 2019·Granted Sep 20, 2022·3 cites·14 claims
- 2191US10988464B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2019·Granted Apr 27, 2021·3 cites·16 claims
- 2290US11040960B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Jun 22, 2021·3 cites·14 claims
- 2390US10759807B2Diaryl substituted 5,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2018·Granted Sep 1, 2020·7 cites·38 claims
- 2490US10487098B2Soluble C5aR antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Nov 26, 2019·6 cites·7 claims
- 2590US9758512B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2016·Granted Sep 12, 2017·6 cites·24 claims
- 2688US12172992B2Pyrimidines for degrading Bruton's tyrosine kinaseABBVIE INC·Filed 2023·Granted Dec 24, 2024·2 cites·3 claims
- 2788US8835419B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2012·Granted Sep 16, 2014·9 cites·30 claims
- 2887US9567323B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2014·Granted Feb 14, 2017·6 cites·9 claims
- 2987US8710236B2Antagonists of the glucagon receptorGOMEZ-GALENO JORGE E·Filed 2011·Granted Apr 29, 2014·10 cites·5 claims
- 3086US10407417B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2017·Granted Sep 10, 2019·3 cites·12 claims
- 3186US9701626B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2015·Granted Jul 11, 2017·5 cites·10 claims
- 3286US9169201B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2014·Granted Oct 27, 2015·8 cites·13 claims
- 3386US8962618B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofREDDY K RAJA·Filed 2012·Granted Feb 24, 2015·7 cites·6 claims
- 3485US11254695B2Soluble C5aR antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Feb 22, 2022·1 cites·16 claims
- 3585US10034891B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·2 cites·4 claims
- 3682US9340566B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·2 cites·10 claims
- 3781US9340509B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2014·Granted May 17, 2016·4 cites·17 claims
- 3880US10239829B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2017·Granted Mar 26, 2019·2 cites·20 claims
- 3980US9795599B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2016·Granted Oct 24, 2017·2 cites·24 claims
- 4080US9790204B2Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2015·Granted Oct 17, 2017·2 cites·38 claims
- 4178US11884654B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2021·Granted Jan 30, 2024·0 cites·15 claims
- 4278US10117865B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2017·Granted Nov 6, 2018·1 cites·6 claims
- 4377US9150550B2Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2013·Granted Oct 6, 2015·2 cites·14 claims
- 4477US8685959B2Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2012·Granted Apr 1, 2014·2 cites·45 claims
- 4576US12011439B2Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitorsCHEMOCENTRYX INC·Filed 2022·Granted Jun 18, 2024·0 cites·10 claims
- 4676US10709718B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·1 cites·11 claims
- 4775US12268675B2Diaryl substituted 6,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2022·Granted Apr 8, 2025·0 cites·16 claims
- 4875US11773091B26-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2022·Granted Oct 3, 2023·0 cites·20 claims
- 4975US11207294B2Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Dec 28, 2021·1 cites·6 claims
- 5074US12054484B2Substituted tetrahydropyrans as CCR2 modulatorsCHEMOCENTRYX INC·Filed 2021·Granted Aug 6, 2024·0 cites·8 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →